Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines

American Journal of Cardiology

Volumn 110, Issue 11, 2012, Pages 1679-1686

  Neilan, Tomas G ^a,b   Coelho Filho, Otavio R ^a   Pena Herrera, Diego ^a   Shah, Ravi V ^a,b   Jerosch Herold, Michael ^a   Francis, Sanjeev A ^b   Moslehi, Javid ^a,c   Kwong, Raymond Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTHRACYCLINE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; WARFARIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CHEMOTHERAPY; CONTRAST ENHANCEMENT; FEMALE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART DEATH; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTHRACYCLINES; CARDIOMYOPATHIES; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; NEOPLASMS; PROGNOSIS; STROKE VOLUME;

EID: 84869090012     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.07.040     Document Type: Article

References (28)

1. R.C. Reulen, D.L. Winter, C. Frobisher, E.R. Lancashire, C.A. Stiller, M.E. Jenney, R. Skinner, M.C. Stevens, M.M. Hawkins British Childhood Cancer Survivor Study Steering Group Long-term cause-specific mortality among survivors of childhood cancer JAMA 304 2010 172 179
2. S.E. Lipshultz, S.D. Colan, R.D. Gelber, A.R. Perez-Atayde, S.E. Sallan, S.P. Sanders Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 1991 808 815
3. L.J. Steinherz, P.G. Steinherz, C.T. Tan, G. Heller, M.L. Murphy Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1991 1672 1677
4. G.M. Felker, R.E. Thompson, J.M. Hare, R.H. Hruban, D.E. Clemetson, D.L. Howard, K.L. Baughman, E.K. Kasper Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
5. P.K. Singal, N. Iliskovic Doxorubicin-induced cardiomyopathy N Engl J Med 339 1998 900 905
6. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, O. Simonetti, F.J. Klocke, R.O. Bonow, R.M. Judd The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
7. O. Bruder, S. Schneider, D. Nothnagel, G. Pilz, M. Lombardi, A. Sinha, A. Wagner, T. Dill, H. Frank, A. van Rossum, J. Schwitter, E. Nagel, J. Senges, G. Sabin, U. Sechtem, H. Mahrholdt Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR registry JACC Cardiovasc Imaging 4 2011 1171 1176
8. R. O'Hanlon, A. Grasso, M. Roughton, J.C. Moon, S. Clark, R. Wage, J. Webb, M. Kulkarni, D. Dawson, L. Sulaibeekh, B. Chandrasekaran, C. Bucciarelli-Ducci, F. Pasquale, M.R. Cowie, W.J. McKenna, M.N. Sheppard, P.M. Elliott, D.J. Pennell, S.K. Prasad Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
9. R. Wassmuth, S. Lentzsch, U. Erdbruegger, J. Schulz-Menger, B. Doerken, R. Dietz, M.G. Friedrich Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study Am Heart J 141 2001 1007 1013
10. R.Y. Kwong, H. Sattar, H. Wu, G. Vorobiof, V. Gandla, K. Steel, S. Siu, K.A. Brown Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction Circulation 118 2008 1011 1020
11. H. Abdel-Aty, P. Boyé, A. Zagrosek, R. Wassmuth, A. Kumar, D. Messroghli, P. Bock, R. Dietz, M.G. Friedrich, J. Schulz-Menger Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches J Am Coll Cardiol 45 2005 1815 1822
12. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
13. S.E. Lipshultz, S.R. Lipsitz, S.E. Sallan, V.M. Dalton, S.M. Mone, R.D. Gelber, S.D. Colan Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia J Clin Oncol 23 2005 2629 2636
14. L. Wang, M. Jerosch-Herold, D.R. Jacobs Jr, E. Shahar, A.R. Folsom Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA) J Am Coll Cardiol 47 2006 565 572
15. C.G. Missouris, S.M. Forbat, D.R. Singer, N.D. Markandu, R. Underwood, G.A. MacGregor Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension J Hypertens 14 1996 1005 1010
16. J.A. McCrohon, J.C. Moon, S.K. Prasad, W.J. McKenna, C.H. Lorenz, A.J. Coats, D.J. Pennell Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
17. B.N. Bernaba, J.B. Chan, C.K. Lai, M.C. Fishbein Pathology of late-onset anthracycline cardiomyopathy Cardiovasc Pathol 19 2010 308 311
18. D.V. Unverferth, J.K. Fetters, B.J. Unverferth, C.V. Leier, R.D. Magorien, A.R. Arn, P.B. Baker Human myocardial histologic characteristics in congestive heart failure Circulation 68 1983 1194 1200
19. R.G. Assomull, S.K. Prasad, J. Lyne, G. Smith, E.D. Burman, M. Khan, M.N. Sheppard, P.A. Poole-Wilson, D.J. Pennell Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
20. C.S. Broberg, S.S. Chugh, C. Conklin, D.J. Sahn, M. Jerosch-Herold Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease Circ Cardiovasc Imaging 3 2010 727 734
21. A.S. Flett, M.P. Hayward, M.T. Ashworth, M.S. Hansen, A.M. Taylor, P.M. Elliott, C. McGregor, J.C. Moon Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
22. J.C. Lightfoot, R.B. D'Agostino Jr, C.A. Hamilton, J. Jordan, F.M. Torti, N.D. Kock, J. Jordan, S. Workman, W.G. Hundley Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model Circ Cardiovasc Imaging 3 2010 550 558
23. M.A. Pfeffer, J.J. McMurray, E.J. Velazquez, J.L. Rouleau, L. Kober, A.P. Maggioni, S.D. Solomon, K. Swedberg, F. Van de Werf, H. White, J.D. Leimberger, M. Henis, S. Edwards, S. Zelenkofske, M.A. Sellers, R.M. Califf Valsartan in Acute Myocardial Infarction Trial Investigators Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906
24. N. Fallah-Rad, J.R. Walker, A. Wassef, M. Lytwyn, S. Bohonis, T. Fang, G. Tian, I.D. Kirkpatrick, P.K. Singal, M. Krahn, D. Grenier, D.S. Jassal The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 57 2011 2263 2270
25. P. Georgakopoulos, P. Roussou, E. Matsakas, A. Karavidas, N. Anagnostopoulos, T. Marinakis, A. Galanopoulos, F. Georgiakodis, S. Zimeras, M. Kyriakidis, A. Ahimastos Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up Am J Hematol 85 2010 894 896
26. M.S. Ewer, M.K. Ali, B. Mackay, S. Wallace, M. Valdivieso, S.S. Legha, R.S. Benjamin, T.P. Haynie A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin J Clin Oncol 2 1984 112 117
27. D. Cardinale, M.T. Sandri, A. Colombo, N. Colombo, M. Boeri, G. Lamantia, M. Civelli, F. Peccatori, G. Martinelli, C. Fiorentini, C.M. Cipolla Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 109 2004 2749 2754
28. T.G. Neilan, D.S. Jassal, T.M. Perez-Sanz, M.J. Raher, A.D. Pradhan, E.S. Buys, F. Ichinose, D.B. Bayne, E.F. Halpern, A.E. Weyman, G. Derumeaux, K.D. Bloch, M.H. Picard, M. Scherrer-Crosbie Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury Eur Heart J 27 2006 1868 1875